Metronidazole (generic), MetroGel Newswire

Metronidazole (generic), MetroGel Newswire

Comprehensive Real-Time News Feed for Metronidazole (generic), MetroGel.

Results 1 - 8 of 8 in Metronidazole (generic), MetroGel

  1. Rosacea Therapeutics Market Is Driven Owing to Rising Awareness Among ...Read the original story w/Photo

    Nov 21, 2016 | SBWire

    Rosacea is a facial skin disorder that affects millions of people around the world; however, awareness about the disease has remained extremely low, with the National Rosacea Society estimating that nearly 95% of sufferers being ignorant about the disease before their diagnosis. Rosacea Therapeutics Market: Introduction Research on how rosacea affects certain individuals is yet to yield any concrete answers.

    Comment?

  2. Nip & tuck with Tracy Mountford: Is there a clever way to calm my red skin?Read the original story w/Photo

    Nov 20, 2016 | Mail on Sunday

    I'm just about to turn 50 and have suffered with rosacea for years. I had thought it might get better with age, but it's worsened.

    Comment?

  3. Rosacea Therapeutics Market - Emerging Trends and New Technologies Research 2016 - 2024Read the original story w/Photo

    Oct 4, 2016 | PR-inside.com

    Transparency Market Research helps companies relevant to rosacea therapeutics strengthen their standing in its global market through a report titled "Rosacea Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024." The report prepares a detailed analysis of the market in terms of multiple factual and statistical facets of the market.

    Comment?

  4. Foamix Pharma Announces Positive Topline Results From Phase 2 Trial...Read the original story w/Photo

    Sep 11, 2016 | BioSpace

    Foamix Pharma Announces Positive Topline Results From Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam For Moderate-To-Severe Papulopustular Rosacea Foamix Pharmaceuticals Ltd. , , a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced the topline results of its Phase 2 clinical trial of FMX103 for the treatment of papulopustular rosacea. Statistically significant differences were demonstrated for improvement in the primary and secondary efficacy endpoints for FMX103 compared with the vehicle-treated group.

    Comment?

  5. Foamix to Announce Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline...Read the original story w/Photo

    Sep 9, 2016 | Freshnews

    Foamix Pharmaceuticals Ltd. , , a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, will announce the results of Phase 2 clinical trial of FMX103 for the treatment of papulopustular rosacea on September 12 , 2016. This was a double-blind, randomized, placebo-controlled Phase 2 trial involving 233 patients who were enrolled in 18 sites throughout Germany.

    Comment?

  6. Foamix Pharma To Announce Topline Results In Phase 2 Clinical Trial...Read the original story

    Sep 8, 2016 | BioSpace

    Foamix Pharma To Announce Topline Results In Phase 2 Clinical Trial Of FMX-103 Minocycline Topical Foam For Moderate-To-Severe Papulopustular Rosacea /PRNewswire/ -- Foamix Pharmaceuticals Ltd. , , a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, will announce the results of Phase 2 clinical trial of FMX103 for the treatment of papulopustular rosacea on This was a double-blind, randomized, placebo-controlled Phase 2 trial involving 233 patients who were enrolled in 18 sites throughout Germany.

    Comment?

  7. Foamix Pharma Announces Completion Of Enrollment In Phase II Clinical ...Read the original story

    May 2, 2016 | BioSpace

    Foamix Pharmaceuticals Ltd. , , a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announced the completion of enrollment in a Phase 2 clinical trial of FMX103 for the treatment of papulopustular rosacea. Papulopustular rosacea is a chronic skin disorder characterized by facial redness and inflammatory lesions.

    Comment?

  8. Rosacea more than just a cosmetic disorderRead the original story

    Apr 9, 2016 | KPC Media Group, Inc.

    When I first learned about rosacea, it was called acne rosacea and the pictures we were shown reminded us of the bulbous noses of Karl Malden and W. C. Fields.

    Comment?